Fig. 3From: Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II studyKaplan-Meier curve of progression-free survival (PFS) in Chinese patients with metastatic pancreatic cancer (MPC)Back to article page